Axess Shows Promise for Living HD Grafts
A synthetic, biocompatible blood vessel becomes colonized by a patient's own tissue. Now tested in 11 patients for more than 600 treatments, the new graft material is safe and works well—with no aneurysms or infections to date.
Read the full article » | Posted 05-12-2022
Related Articles
- VenoStent, Inc. is Recruiting Patients for a Clinical Trial of the SelfWrap Posted 10-14-2025
- Diality Treated its First Patient in the Moda-flx Home IDE PRESCRIBE Cinical Trial Posted 10-14-2025
- eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant Posted 09-15-2025
- The First Artificial Kidney Built in Canada has Ties to London: A Revolution in Care for Patients with Kidney Failure Posted 09-15-2025

